$SENS
Senseonics Holdings, Inc.

2023 Q4 Form 10-Q Financial Statement

#000155837023018596 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $8.030M $6.097M
YoY Change 44.14% 31.91%
Cost Of Revenue $6.941M $4.925M
YoY Change 40.17% 27.39%
Gross Profit $1.089M $1.200M
YoY Change 75.93% 58.73%
Gross Profit Margin 13.56% 19.68%
Selling, General & Admin $7.344M $7.425M
YoY Change -6.43% 1.16%
% of Gross Profit 674.38% 618.75%
Research & Development $10.75M $12.77M
YoY Change -7.58% 16.24%
% of Gross Profit 987.05% 1064.08%
Depreciation & Amortization $636.0K $187.0K
YoY Change 171.79% -19.05%
% of Gross Profit 58.4% 15.58%
Operating Expenses $18.09M $20.19M
YoY Change -7.12% 10.2%
Operating Profit -$17.00M -$19.02M
YoY Change -9.85% 8.27%
Interest Expense -$194.0K $2.425M
YoY Change -100.64% -49.49%
% of Operating Profit
Other Income/Expense, Net $8.000K -$5.081M
YoY Change -20.0% -88.13%
Pretax Income -$17.19M -$24.10M
YoY Change -248.69% -60.09%
Income Tax
% Of Pretax Income
Net Earnings -$17.19M -$24.10M
YoY Change -248.69% -60.09%
Net Earnings / Revenue -214.07% -395.33%
Basic Earnings Per Share -$0.04
Diluted Earnings Per Share -$0.03 -$0.04
COMMON SHARES
Basic Shares Outstanding 528.3M 492.9M
Diluted Shares Outstanding 592.5M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $109.5M $125.4M
YoY Change -29.96% -23.09%
Cash & Equivalents $75.71M $55.76M
Short-Term Investments $33.75M $69.65M
Other Short-Term Assets $5.201M $5.546M
YoY Change -26.66% 3.76%
Inventory $8.776M $9.726M
Prepaid Expenses
Receivables $4.532M $3.450M
Other Receivables $2.065M $2.011M
Total Short-Term Assets $130.0M $146.1M
YoY Change -19.34% -13.68%
LONG-TERM ASSETS
Property, Plant & Equipment $1.184M $934.0K
YoY Change 6.47% -21.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change -100.0% -100.0%
Other Assets $1.826M $1.730M
YoY Change 2302.63% -48.23%
Total Long-Term Assets $8.190M $7.925M
YoY Change -50.28% -40.75%
TOTAL ASSETS
Total Short-Term Assets $130.0M $146.1M
Total Long-Term Assets $8.190M $7.925M
Total Assets $138.2M $154.1M
YoY Change -22.21% -15.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.568M $2.669M
YoY Change 990.21% 290.2%
Accrued Expenses $12.66M $14.63M
YoY Change -17.99% 9.85%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $17.26M $17.30M
YoY Change -45.17% -69.99%
LONG-TERM LIABILITIES
Long-Term Debt $41.20M $40.49M
YoY Change -26.94% -24.23%
Other Long-Term Liabilities $6.214M $6.312M
YoY Change 131.09% 120.78%
Total Long-Term Liabilities $6.214M $6.312M
YoY Change 131.09% 120.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.26M $17.30M
Total Long-Term Liabilities $6.214M $6.312M
Total Liabilities $64.77M $64.34M
YoY Change -54.58% -67.46%
SHAREHOLDERS EQUITY
Retained Earnings -$869.3M -$852.1M
YoY Change 7.47% 3.86%
Common Stock $530.0K $528.0K
YoY Change 10.42% 10.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $35.80M $52.07M
YoY Change
Total Liabilities & Shareholders Equity $138.2M $154.1M
YoY Change -22.21% -15.66%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$17.19M -$24.10M
YoY Change -248.69% -60.09%
Depreciation, Depletion And Amortization $636.0K $187.0K
YoY Change 171.79% -19.05%
Cash From Operating Activities -$15.07M -$17.26M
YoY Change -13.34% 18.38%
INVESTING ACTIVITIES
Capital Expenditures $170.0K $123.0K
YoY Change 198.25% -379.55%
Acquisitions
YoY Change
Other Investing Activities $36.37M $27.77M
YoY Change 390.95% -223.25%
Cash From Investing Activities $36.19M $27.65M
YoY Change 392.45% -222.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.178M 16.83M
YoY Change -111.39% -38.19%
NET CHANGE
Cash From Operating Activities -15.07M -17.26M
Cash From Investing Activities 36.19M 27.65M
Cash From Financing Activities -1.178M 16.83M
Net Change In Cash 19.95M 27.21M
YoY Change 6356.31% -373.69%
FREE CASH FLOW
Cash From Operating Activities -$15.07M -$17.26M
Capital Expenditures $170.0K $123.0K
Free Cash Flow -$15.24M -$17.39M
YoY Change -12.65% 19.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001616543
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
479637138
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
528176273
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.senseonics.com/20230930#DepositsAndOtherAssetsNoncurrent
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.senseonics.com/20230930#DepositsAndOtherAssetsNoncurrent
CY2023Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.senseonics.com/20230930#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.senseonics.com/20230930#AccruedLiabilitiesAndOtherLiabilitiesCurrent
CY2023Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37717
dei Entity Registrant Name
EntityRegistrantName
Senseonics Holdings, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-1210911
dei Entity Address Address Line1
EntityAddressAddressLine1
20451 Seneca Meadows Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
Germantown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20876-7005
dei City Area Code
CityAreaCode
301
dei Local Phone Number
LocalPhoneNumber
515-7260
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
SENS
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
528281405
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55759000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35793000
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
69648000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
108222000
CY2023Q3 us-gaap Inventory Net
InventoryNet
9726000
CY2022Q4 us-gaap Inventory Net
InventoryNet
7306000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7557000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7428000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
146140000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
161200000
CY2023Q3 sens Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
6991000
CY2022Q4 sens Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
3108000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
12253000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
934000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1112000
CY2023Q3 us-gaap Assets
Assets
154065000
CY2022Q4 us-gaap Assets
Assets
177673000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2669000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
419000
CY2022Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
15579000
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
20000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
17302000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
31471000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
40485000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
56383000
CY2023Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
245000
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
52050000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6312000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2689000
CY2023Q3 us-gaap Liabilities
Liabilities
64344000
CY2022Q4 us-gaap Liabilities
Liabilities
142593000
CY2023Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
12000
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
12000
CY2023Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
12000
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
12000
CY2023Q3 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
37656000
CY2022Q4 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
37656000
CY2023Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
37656000
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
37656000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
528176273
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
479637138
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
528000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
480000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
903665000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
806488000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-59000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-678000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-852069000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-808866000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
52065000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2576000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
154065000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
177673000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6097000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4622000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14360000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10818000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4925000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3866000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12358000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8711000
CY2023Q3 us-gaap Gross Profit
GrossProfit
1172000
CY2022Q3 us-gaap Gross Profit
GrossProfit
756000
us-gaap Gross Profit
GrossProfit
2002000
us-gaap Gross Profit
GrossProfit
2107000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12769000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10985000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38003000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28088000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7425000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7340000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22598000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23785000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-19022000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-17569000
us-gaap Operating Income Loss
OperatingIncomeLoss
-58599000
us-gaap Operating Income Loss
OperatingIncomeLoss
-49766000
CY2023Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1460000
CY2022Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
544000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
3879000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
878000
CY2022Q3 sens Nonoperating Gain Loss Fair Value Adjustment
NonoperatingGainLossFairValueAdjustment
-8592000
sens Nonoperating Gain Loss Fair Value Adjustment
NonoperatingGainLossFairValueAdjustment
41333000
CY2023Q3 sens Nonoperating Gain Loss Exchanges
NonoperatingGainLossExchanges
-4569000
sens Nonoperating Gain Loss Exchanges
NonoperatingGainLossExchanges
14207000
CY2023Q3 us-gaap Interest Expense
InterestExpense
2425000
CY2022Q3 us-gaap Interest Expense
InterestExpense
4801000
us-gaap Interest Expense
InterestExpense
9388000
us-gaap Interest Expense
InterestExpense
13806000
CY2023Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
438000
CY2022Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-28948000
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
6505000
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
152169000
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
984000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
138000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-41000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
194000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-112000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5081000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-42822000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15397000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
180324000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24103000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-60391000
us-gaap Net Income Loss
NetIncomeLoss
-43202000
us-gaap Net Income Loss
NetIncomeLoss
130558000
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
61000
CY2022Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-57000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
619000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-973000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
61000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-57000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
619000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-973000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24042000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-60448000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42583000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
129585000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
592452262
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
472475747
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
552703546
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
464244736
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
592452262
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
472475747
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
552703546
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
608345713
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
15941000
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
26439000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
712000
CY2022Q3 sens Issued Common Stock For Vested Rsus And Espp Purchase
IssuedCommonStockForVestedRsusAndEsppPurchase
69000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2222000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-60391000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-57000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-15065000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-185535000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
34443000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
951000
sens Issued Common Stock For Vested Rsus And Espp Purchase
IssuedCommonStockForVestedRsusAndEsppPurchase
132000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
6543000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1184000
us-gaap Net Income Loss
NetIncomeLoss
130558000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-973000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-15065000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
52537000
CY2023Q3 sens Issued Common Stock For Vested Rsus And Espp Purchase
IssuedCommonStockForVestedRsusAndEsppPurchase
118000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
21002000
CY2023Q3 sens Adjustments To Additional Paid In Capital Warrants Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedIssuanceCosts
-363000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2084000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24103000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
61000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
52065000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2576000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7376000
sens Issued Common Stock For Vested Rsus And Espp Purchase
IssuedCommonStockForVestedRsusAndEsppPurchase
205000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
63645000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
21002000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
6735000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1603000
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-137000
us-gaap Net Income Loss
NetIncomeLoss
-43202000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
619000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
52065000
us-gaap Profit Loss
ProfitLoss
-43202000
us-gaap Profit Loss
ProfitLoss
130558000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
641000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
751000
sens Amortization Of Financing Costs Discounts And Deferred Costs
AmortizationOfFinancingCostsDiscountsAndDeferredCosts
6581000
sens Amortization Of Financing Costs Discounts And Deferred Costs
AmortizationOfFinancingCostsDiscountsAndDeferredCosts
8858000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2253000
sens Fair Value Adjustment Derivative Liability
FairValueAdjustmentDerivativeLiability
-6505000
sens Fair Value Adjustment Derivative Liability
FairValueAdjustmentDerivativeLiability
-152169000
sens Nonoperating Gain Loss Fair Value Adjustment
NonoperatingGainLossFairValueAdjustment
41333000
sens Nonoperating Gain Loss Exchanges
NonoperatingGainLossExchanges
14207000
sens Impairment Of Options
ImpairmentOfOptions
-138000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2944000
us-gaap Share Based Compensation
ShareBasedCompensation
6735000
us-gaap Share Based Compensation
ShareBasedCompensation
6543000
us-gaap Inventory Write Down
InventoryWriteDown
89000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-5000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
56000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
998000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
151000
sens Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
129000
sens Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-504000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2509000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
941000
sens Increase Decrease In Deposit Assets And Other Assets
IncreaseDecreaseInDepositAssetsAndOtherAssets
342000
sens Increase Decrease In Deposit Assets And Other Assets
IncreaseDecreaseInDepositAssetsAndOtherAssets
-163000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
669000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-519000
sens Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
1161000
sens Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
-1070000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-292000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-257000
sens Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-596000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-55096000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48925000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
180000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
255000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
68537000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
82807000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
122235000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
102594000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
53518000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
19532000
sens Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
7376000
sens Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
34443000
sens Proceeds From Issuance Of Stock Options
ProceedsFromIssuanceOfStockOptions
71000
sens Proceeds From Issuance Of Stock Options
ProceedsFromIssuanceOfStockOptions
1083000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1603000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1184000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2926000
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
24446000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
244000
sens Proceeds From Issuance Of Warrants Net
ProceedsFromIssuanceOfWarrantsNet
14698000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21544000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31416000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19966000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2023000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35793000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33461000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55759000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35484000
us-gaap Interest Paid Net
InterestPaidNet
3100000
us-gaap Interest Paid Net
InterestPaidNet
5137000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3831000
sens Issuance Of Warrant In Exchange For Phc Notes
IssuanceOfWarrantInExchangeForPhcNotes
48564000
sens Issuance Of Warrants For Loan And Security Agreement
IssuanceOfWarrantsForLoanAndSecurityAgreement
364000
us-gaap Stock Issued1
StockIssued1
21002000
CY2022 us-gaap Gross Profit
GrossProfit
2700000
CY2021 us-gaap Gross Profit
GrossProfit
-800000
CY2020 us-gaap Gross Profit
GrossProfit
-17400000
CY2023Q3 us-gaap Gross Profit
GrossProfit
1200000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-852100000
CY2023Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
125400000
CY2023Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
15000000.0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2811493
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
592452262
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses during the reporting period. In the accompanying unaudited consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, recoverability of long-lived assets, deferred taxes and valuation allowances, fair value of investments, derivative assets and liabilities, obsolete inventory, warranty </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">obligations, variable consideration related to revenue, allowance for credit losses, depreciable lives of property and equipment, and accruals for clinical study costs, which are accrued based on estimates of work performed under contract. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenues and expenses. Actual results could differ from those estimates; however, management does not believe that such differences would be material.</p>
sens Number Of Geographical Markets
NumberOfGeographicalMarkets
2
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6097000
CY2023Q3 sens Revenue By Geographical Region Percentage
RevenueByGeographicalRegionPercentage
1.000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14360000
sens Revenue By Geographical Region Percentage
RevenueByGeographicalRegionPercentage
1.000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4622000
CY2022Q3 sens Revenue By Geographical Region Percentage
RevenueByGeographicalRegionPercentage
1.000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10818000
sens Revenue By Geographical Region Percentage
RevenueByGeographicalRegionPercentage
1.000
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1300000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1700000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-24103000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-60391000
us-gaap Net Income Loss
NetIncomeLoss
-43202000
us-gaap Net Income Loss
NetIncomeLoss
130558000
us-gaap Dilutive Securities
DilutiveSecurities
-188563000
CY2023Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-24103000
CY2022Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-60391000
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-43202000
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-58005000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
592452262
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
472475747
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
552703546
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
464244736
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6499671
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
472475747
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
552703546
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
608345713
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
79208079
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
202155412
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
79208079
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
33571457
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
69707000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
59000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
69648000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
121153000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
678000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
120475000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
36156000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
39231000
CY2023Q3 sens Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date Year Two
DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateYearTwo
33551000
CY2023Q3 sens Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Two
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo
30417000
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
69707000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
69648000
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2440000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1697000
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5981000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4057000
CY2023Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
1305000
CY2022Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
1552000
CY2023Q3 us-gaap Inventory Net
InventoryNet
9726000
CY2022Q4 us-gaap Inventory Net
InventoryNet
7306000
CY2023Q3 sens Prepaid Contract Manufacturing Current
PrepaidContractManufacturingCurrent
4577000
CY2022Q4 sens Prepaid Contract Manufacturing Current
PrepaidContractManufacturingCurrent
4097000
CY2023Q3 sens Tax Credits Receivable
TaxCreditsReceivable
1793000
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
340000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1243000
CY2023Q3 sens Prepaid Clinical And Preclinical Costs
PrepaidClinicalAndPreclinicalCosts
180000
CY2022Q4 sens Prepaid Clinical And Preclinical Costs
PrepaidClinicalAndPreclinicalCosts
924000
CY2023Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
218000
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
336000
CY2023Q3 us-gaap Prepaid Rent
PrepaidRent
151000
CY2022Q4 us-gaap Prepaid Rent
PrepaidRent
132000
CY2023Q3 sens Research And Development
ResearchAndDevelopment
135000
CY2022Q4 sens Research And Development
ResearchAndDevelopment
67000
CY2023Q3 sens Prepaid Accounting And Audit
PrepaidAccountingAndAudit
117000
CY2022Q4 sens Prepaid Accounting And Audit
PrepaidAccountingAndAudit
270000
CY2023Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
46000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
359000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7557000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7428000
CY2023Q3 sens Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
4168000
CY2022Q4 sens Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
3502000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3947000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1053000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3569000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4699000
CY2023Q3 sens Accrued Contract Manufacturing Costs Current
AccruedContractManufacturingCostsCurrent
1396000
CY2022Q4 sens Accrued Contract Manufacturing Costs Current
AccruedContractManufacturingCostsCurrent
2480000
CY2023Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
517000
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
781000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
413000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
725000
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
381000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
149000
CY2023Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
242000
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2050000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14000
CY2023Q3 sens Accrued Liabilities And Other Liabilities Including Related Party Current
AccruedLiabilitiesAndOtherLiabilitiesIncludingRelatedPartyCurrent
14633000
CY2022Q4 sens Accrued Liabilities And Other Liabilities Including Related Party Current
AccruedLiabilitiesAndOtherLiabilitiesIncludingRelatedPartyCurrent
15453000
us-gaap Operating Lease Expense
OperatingLeaseExpense
600000
us-gaap Operating Lease Expense
OperatingLeaseExpense
500000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5261000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3032000
CY2023Q3 sens Tenant Improvement Allowance Receivable
TenantImprovementAllowanceReceivable
1312000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
413000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
725000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6312000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2689000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
6725000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3414000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
283000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
912000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
939000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
967000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
996000
CY2023Q3 sens Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
5934000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10031000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3306000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
6725000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y7M6D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085
sens Product Warranty Term
ProductWarrantyTerm
P1Y
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
500000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
800000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
781000
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
723000
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
136000
CY2022 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
166000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
400000
CY2022 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
108000
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
517000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
781000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2808000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6408000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
172000
us-gaap Interest Expense Debt
InterestExpenseDebt
9388000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
4945000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
8576000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
283000
us-gaap Interest Expense Debt
InterestExpenseDebt
13803000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
20399000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
7397000
CY2023Q3 sens Long Term Debt Maturities Repayments Of Principal After Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearThree
19341000
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
47137000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0

Files In Submission

Name View Source Status
0001558370-23-018596-index-headers.html Edgar Link pending
0001558370-23-018596-index.html Edgar Link pending
0001558370-23-018596.txt Edgar Link pending
0001558370-23-018596-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sens-20230930.xsd Edgar Link pending
sens-20230930x10q.htm Edgar Link pending
sens-20230930xex31d1.htm Edgar Link pending
sens-20230930xex31d2.htm Edgar Link pending
sens-20230930xex32d1.htm Edgar Link pending
Show.js Edgar Link pending
sens-20230930_def.xml Edgar Link unprocessable
sens-20230930_lab.xml Edgar Link unprocessable
sens-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
sens-20230930x10q_htm.xml Edgar Link completed
sens-20230930_cal.xml Edgar Link unprocessable